PFIZER INC — Earnings Release 2010

Nov 2, 2010

8-K 1 v200593_8k.htm Licensed to: Vintage Filings Document Created using EDGARizer 4.0.6.4 Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): November 2, 2010

PFIZER INC.

(Exact name of registrant as specified in its charter)

Delaware	1-3619	13-5315170
(State
or other	(Commission
File	(I.R.S.
Employer
jurisdiction
of	(Number)	Identification
No.)
incorporation)

| 235
East 42nd Street | 10017 |
| --- | --- |
| New
York, New York | (Zip
Code) |

(Address of principal executive offices)

Registrant's telephone number, including area code:

(212) 733-2323

Not Applicable

(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition

On November 2, 2010, Pfizer Inc. (“Pfizer”) issued a press release announcing its financial results for the third quarter of 2010. The information contained in the press release is deemed to be “filed” under the Securities Exchange Act of 1934 as Exhibit 99 to this report, and such press release is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit 99 - Press Release of Pfizer Inc. dated November 2, 2010, reporting Pfizer's financial results for the third quarter of 2010. Exhibit 99 is deemed to be “filed” under the Securities Exchange Act of 1934 in this Current Report on Form 8-K.

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

| PFIZER
INC. | |
| --- | --- |
| By: | /s/ Matthew Lepore |
| | Matthew
Lepore |
| | Vice
President, Chief Counsel – Corporate Governance, |
| | and
Assistant General Counsel |

Dated: November 2, 2010

EXHIBIT INDEX

| Exhibit
No. | Description |
| --- | --- |
| 99 | Press
Release of Pfizer Inc. dated November 2, 2010, reporting Pfizer's
financial results for the third quarter of
2010. |